New approach to cancer therapy based on a molecularly defined cancer classification-Reference-Cited by-同舟云学术

New approach to cancer therapy based on a molecularly defined cancer classification

Published:2013-11-18 Issue:1 Volume:64 Page:70-74
ISSN:0007-9235
Container-title:CA: A Cancer Journal for Clinicians
language:en
Short-container-title:CA A Cancer Journal for Clinicians

Author:

Cortés Javier¹²,Calvo Emiliano³,Vivancos Ana⁴,Perez-Garcia Jose⁵,Recio Juan Angel⁶,Seoane Joan⁷

Affiliation:

1. Head of the Breast Cancer and Melanoma Programs; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital; Barcelona Spain

2. Medical Oncologist; Medica Scientia Innovation Research (MedSIR); Barcelona Spain

3. Director of Clinical Research; South Texas Accelerated Research Therapeutics (START) Madrid, Early Clinical Drug Development Program, Clara Campal Cancer Center; Madrid Spain

4. Head of the Genomic Program; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital; Barcelona Spain

5. Medical Oncologist; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital; Barcelona Spain

6. Lab head of the Animal Models and Cancer Laboratory; Vall d'Hebron Institute of Research, Vall d'Hebron University Hospital; Barcelona Spain

7. Head of the Gene Expression and Cancer Laboratory; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital; Barcelona Spain

Publisher

Wiley

Subject

Oncology,Hematology

Reference41 articles.

1. Cancer. Addiction to oncogenes-the Achilles heal of cancer;Weinstein;Science,2002

2. Suppression of BRAF(V599E) in human melanoma abrogates transformation;Hingorani;Cancer Res,2003

3. p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor;Hudziak;Mol Cell Biol,1989

4. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

5. Mutations of the BRAF gene in human cancer;Davies;Nature,2012

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histology-agnostic approvals for antibody–drug conjugates in solid tumours: is the time ripe?;European Journal of Cancer;2022-08

2. Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards;ESMO Open;2021-04

3. Pan-Cancer Molecular Patterns and Biological Implications Associated with a Tumor-Specific Molecular Signature;Cells;2020-12-31

4. Multiple primary malignancies involving lung cancer: a single-center experience;Tumori Journal;2020-06-24

5. Supramolecular Vesicles of β-CD Dimer as Enzyme Carrier for Cancer Therapy;Chemistry Letters;2019-12-05